Extraneous matter specification establishes acceptable limits for foreign objects including glass, metal, and fibre contamination within pharmaceutical products. Visual inspection identifies visible contamination. Mechanical sieving removes particles above specified sizes. Metal detection systems identify ferrous contaminants. Regulatory specifications establish zero acceptable levels for certain contaminant types.
Manufacturing environment controls minimise extraneous matter generation. Equipment inspection prevents debris shedding. Container-closure materials require validation confirming integrity. Regulatory inspections assess manufacturing practices preventing contamination. Recall procedures address discovered contaminated products protecting patient safety.
General Biopharmaceutical Concepts
Extraneous Matter Specification
Extraneous Matter Specification defines acceptable limits for foreign particles or contaminants to ensure pharmaceutical product quality and safety.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →